|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Suzuki H, Oda I, Abe S, Sekiguchi M, Mori
G, Nonaka S, Yoshinaga S and Saito Y: High rate of 5-year survival
among patients with early gastric cancer undergoing curative
endoscopic submucosal dissection. Gastric Cancer. 19:198–205. 2016.
View Article : Google Scholar
|
|
3
|
Hsu A, Chudasama R, Almhanna K and Raufi
A: Targeted therapies for gastroesophageal cancers. Ann Transl Med.
8:11042020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hunt RH, Camilleri M, Crowe SE, El-Omar
EM, Fox JG, Kuipers EJ, Malfertheiner P, McColl KE, Pritchard DM,
Rugge M, et al: The stomach in health and disease. Gut.
64:1650–1668. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dolcetti R, De Re V and Canzonieri V:
Immunotherapy for Gastric Cancer: Time for a personalized approach?
Int J Mol Sci. 19:16022018. View Article : Google Scholar :
|
|
6
|
Cheng HS, Lee JXT, Wahli W and Tan NS:
Exploiting vulnerabilities of cancer by targeting nuclear receptors
of stromal cells in tumor microenvironment. Mol Cancer. 18:512019.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhou ZX and Lu ZR: Molecular imaging of
the tumor microen-vironment. Adv Drug Deliver Rev. 113:24–48. 2017.
View Article : Google Scholar
|
|
8
|
Denton AE, Roberts EW and Fearon DT:
Stromal Cells in the Tumor Microenvironment. Adv Exp Med Biol.
1060:99–114. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhan HX, Zhou B, Cheng YG, Xu JW, Wang L,
Zhang GY and Hu SY: Crosstalk between stromal cells and cancer
cells in pancreatic cancer: New insights into stromal biology.
Cancer Lett. 392:83–93. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen DX, Chen G, Jiang W, Fu M, Liu W, Sui
J, Xu S, Liu Z, Zheng X, Chi L, et al: Association of the collagen
signature in the tumor microenvironment with lymph node metastasis
in early gastric cancer. JAMA Surg. 154:e1852492019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hodgson A, Xu B, Satkunasivam R and Downes
MR: Tumour front inflammation and necrosis are independent
prognostic predictors in high-grade urothelial carcinoma of the
bladder. J Clin Pathol. 71:154–160. 2018. View Article : Google Scholar
|
|
12
|
Patil S and Singh N: Spatially controlled
functional group grafting of silk films to induce osteogenic and
chondrogenic differentiation of human mesenchymal stem cells. Mater
Sci Eng C Mater Biol Appl. 91:796–805. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ghaneialvar H, Soltani L, Rahmani HR,
Lotfi AS and Soleimani M: Characterization and classification of
mesenchymal stem cells in several species using surface markers for
cell therapy purposes. Indian J Clin Biochem. 33:46–52. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schafer R and Bieback K: Characterization
of mesenchymal stem or stromal cells: Tissue sources,
heterogeneity, and function. Transfusion. 56:S2–S5. 2016.
View Article : Google Scholar
|
|
15
|
Wang Y, Chen X, Cao W and Shi Y:
Plasticity of mesenchymal stem cells in immunomodulation:
Pathological and therapeutic implications. Nat Immunol.
15:1009–1016. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zong C, Zhang HJ, Yang X, Gao L, Hou J, Ye
F, Jiang J, Yang Y, Li R, Han Z and Wei L: The distinct roles of
mesenchymal stem cells in the initial and progressive stage of
hepatocarcinoma. Cell Death Dis. 9:3452018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang X, Hu FY, Li G, Li G, Yang X, Liu L,
Zhang R, Zhang B and Feng Y: Human colorectal cancer-derived
mesenchymal stem cells promote colorectal cancer progression
through IL-6/JAK2/STAT3 signaling. Cell Death Dis. 9:252018.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dvorak HF: Tumors: Wounds that do not
heal. Similarities between tumor stroma generation and wound
healing. N Engl J Med. 315:1650–1659. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen J, Ma L, Zhang N, Zhu Y, Zhang K, Xu
Z and Wang Q: Mesenchymal stem cells promote tumor progression via
inducing stroma remodeling on rabbit VX2 bladder tumor model. Int J
Biol Sci. 14:1012–1021. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gao T, Yu Y, Cong Q, Wang Y, Sun M, Yao L,
Xu C and Jiang W: Human mesenchymal stem cells in the tumour
micro-environment promote ovarian cancer progression: The role of
platelet-activating factor. BMC Cancer. 18:9992018. View Article : Google Scholar
|
|
21
|
Shojaei S, Hashemi SM, Ghanbarian H,
Salehi M and Mohammadi-Yeganeh S: Effect of mesenchymal stem
cells-derived exosomes on tumor microenvironment: Tumor progression
versus tumor suppression. J Cell Physiol. 234:3394–3409. 2019.
View Article : Google Scholar
|
|
22
|
Worner PM, Schachtele DJ, Barabadi Z,
Srivastav S, Chandrasekar B, Izadpanah R and Alt EU: Breast tumor
micro-environment can transform naive mesenchymal stem cells into
tumor-forming cells in nude mice. Stem Cells Dev. 28:341–352. 2019.
View Article : Google Scholar
|
|
23
|
Shi Y, Du L, Lin L and Wang Y:
Tumour-associated mesenchymal stem/stromal cells: Emerging
therapeutic targets. Nat Rev Drug Discov. 16:35–52. 2017.
View Article : Google Scholar
|
|
24
|
Friedenstein AJ, Chailakhjan RK and
Lalykina KS: The development of fibroblast colonies in monolayer
cultures of guinea-pig bone marrow and spleen cells. Cell Tissue
Kine. 3:393–403. 1970.
|
|
25
|
Mushahary D, Spittler A, Kasper C, Weber V
and Charwat V: Isolation, cultivation, and characterization of
human mesen-chymal stem cells. Cytometry A. 93:19–31. 2018.
View Article : Google Scholar
|
|
26
|
Xu X, Zhang X, Wang S, Qian H, Zhu W, Cao
H, Wang M, Chen Y and Xu W: Isolation and comparison of mesenchymal
stem-like cells from human gastric cancer and adjacent
non-cancerous tissues. J Cancer Res Clin. 137:495–504. 2011.
View Article : Google Scholar
|
|
27
|
Cao H, Xu W, Qian H, Zhu W, Yan Y, Zhou H,
Zhang X and Xu X, Li J, Chen Z and Xu X: Mesenchymal stem cell-like
cells derived from human gastric cancer tissues. Cancer Lett.
274:61–71. 2009. View Article : Google Scholar
|
|
28
|
Sun L, Wang Q, Chen B, Zhao Y, Shen B,
Wang X, Zhu M, Li Z, Zhao X, Xu C, et al: Human gastric cancer
mesenchymal stem cell-derived IL15 contributes to tumor cell
epithelial-mesenchymal transition via upregulation tregs ratio and
PD-1 expression in CD4 + T cell. Stem Cells Dev.
27:1203–1214. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhu Q, Zhang X, Zhang L, Li W, Wu H, Yuan
X, Mao F, Wang M, Zhu W, Qian H and Xu W: The IL-6-STAT3 axis
mediates a reciprocal crosstalk between cancer-derived mesenchymal
stem cells and neutrophils to synergistically prompt gastric cancer
progression. Cell Death Dis. 5:e12952014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li W, Zhou Y, Yang J, Zhang X, Zhang H,
Zhang T, Zhao S, Zheng P, Huo J and Wu H: Gastric cancer-derived
mesenchymal stem cells prompt gastric cancer progression through
secretion of interleukin-8. J Exp Clin Cancer Res. 34:522015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cao M, Mao J, Duan X, Lu L, Zhang F, Lin
B, Chen M, Zheng C, Zhang X and Shen J: In vivo tracking of the
tropism of mesenchymal stem cells to malignant gliomas using
reporter gene-based MR imaging. Int J Cancer. 142:1033–1046. 2018.
View Article : Google Scholar
|
|
32
|
Chen Y, He Y, Wang X, Lu F and Gao J:
Adiposederived mesenchymal stem cells exhibit tumor tropism and
promote tumorsphere formation of breast cancer cells. Oncol Rep.
41:2126–2136. 2019.PubMed/NCBI
|
|
33
|
Chaturvedi P, Gilkes DM, Takano N and
Semenza GL: Hypoxia-inducible factor-dependent signaling between
triple-negative breast cancer cells and mesenchymal stem cells
promotes macrophage recruitment. Proc Natl Acad Sci USA.
111:E2120–E2129. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jung YH, Kim JK, Shiozawa Y, Wang J,
Mishra A, Joseph J, Berry JE, McGee S, Lee E, Sun H, et al:
Recruitment of mesenchymal stem cells into prostate tumours
promotes metastasis. Nat Commun. 4:17952013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Camorani S, Hill BS, Fontanella R, Greco
A, Gramanzini M, Auletta L, Gargiulo S, Albanese S, Lucarelli E,
Cerchia L and Zannetti A: Inhibition of bone marrow-derived
mesenchymal stem cells homing towards triple-negative breast cancer
micro-environment using an Anti-PDGFRβ Aptamer. Theranostics.
7:3595–3607. 2017. View Article : Google Scholar :
|
|
36
|
Barcellos-de-Souza P, Comito G,
Pons-Segura C, Taddei ML, Gori V, Becherucci V, Bambi F, Margheri
F, Laurenzana A, Del Rosso M and Chiarugi P: Mesenchymal stem cells
are recruited and activated into carcinoma-associated fibroblasts
by prostate cancer microenvironment-derived TGF-β1. Stem Cells.
34:2536–2547. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Pavon LF, Sibov TT, de Souza AV, da Cruz
EF, Malheiros SMF, Cabral FR, de Souza JG, Boufleur P, de Oliveira
DM, de Toledo SRC, et al: Tropism of mesenchymal stem cell toward
CD133+ stem cell of glioblastoma in vitro and promote
tumor proliferation in vivo. Stem Cell Res Ther. 9:3102018.
View Article : Google Scholar
|
|
38
|
Berger L, Shamai Y, Skorecki KL and
Tzukerman M: Tumor specific recruitment and reprogramming of
mesenchymal stem cells in tumorigenesis. Stem Cells. 34:1011–1026.
2016. View Article : Google Scholar
|
|
39
|
Shamai Y, Alperovich DC, Yakhini Z,
Skorecki K and Tzukerman M: Reciprocal reprogramming of cancer
cells and associated mesenchymal stem cells in gastric cancer. Stem
Cells. 37:176–189. 2019. View Article : Google Scholar
|
|
40
|
Shen Y, Xue C, Li X, Ba L, Gu J, Sun Z,
Han Q and Zhao RC: Effects of gastric cancer cell-derived exosomes
on the immune regulation of mesenchymal stem cells by the NF-κB
signaling pathway. Stem Cells Dev. 28:464–476. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhu M, Wang M, Yang F, Tian Y, Cai J, Yang
H, Fu H, Mao F, Zhu W, Qian H and Xu W: miR-155-5p inhibition
promotes the transition of bone marrow mesenchymal stem cells to
gastric cancer tissue derived MSC-like cells via NF-κ B p65
activation. Oncotarget. 7:16567–16580. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ji RB, Zhang X, Qian H, Gu H, Sun Z, Mao
F, Yan Y, Chen J, Liang Z and Xu W: miR-374 mediates the malignant
transformation of gastric cancer-associated mesenchymal stem cells
in an experimental rat model. Oncol Rep. 38:1473–1481. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sun Z, Chen J, Zhang J, Ji R, Xu W, Zhang
X and Qian H: The role and mechanism of miR-374 regulating the
malignant transformation of mesenchymal stem cells. Am J Transl
Res. 10:3224–3232. 2018.PubMed/NCBI
|
|
44
|
Yang T, Zhang X, Wang M, Zhang J, Huang F,
Cai J, Zhang Q, Mao F, Zhu W, Qian H and Xu W: Activation of
mesenchymal stem cells by macrophages prompts human gastric cancer
growth through NF-κ B pathway. PLoS One. 9:e975692014. View Article : Google Scholar
|
|
45
|
Xu R, Zhao X, Zhao Y, Chen B, Sun L, Xu C,
Shen B, Wang M, Xu W and Zhu W: Enhanced gastric cancer growth
potential of mesenchymal stem cells derived from gastric cancer
tissues educated by CD4+ T cells. Cell Prolif.
51:e123992018. View Article : Google Scholar
|
|
46
|
Zhang Q, Ding J, Liu J, Wang W, Zhang F,
Wang J and Li Y: Helicobacter pylori-infected MSCs acquire a
pro-inflammatory phenotype and induce human gastric cancer
migration by promoting EMT in gastric cancer cells. Oncol Lett.
11:449–457. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Vafaei R, Nassiri SM and Siavashi V:
3-Adrenergic regulation of EPC features through manipulation of the
bone marrow MSC niche. J Cell Biochem. 118:4753–4761. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Yang Y, Bucan V, Baehre H, Von der Ohe J,
Otte A and Hass R: Acquisition of new tumor cell properties by
MSC-derived exosomes. Int J Oncol. 47:244–252. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Whiteside TL: Exosome and mesenchymal stem
cell cross-talk in the tumor microenvironment. Semin Immunol.
35:69–79. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Huang F, Wang M, Yang T, Cai J, Zhang Q,
Sun Z, Wu X, Zhang X, Zhu W, Qian H and Xu W: Gastric
cancer-derived MSC-secreted PDGF-DD promotes gastric cancer
progression. J Cancer Res Clin. 140:1835–1848. 2014. View Article : Google Scholar
|
|
51
|
Huang F, Yao Y, Wu J, Liu Q, Zhang J, Pu
X, Zhang Q and Xia L: Curcumin inhibits gastric cancer-derived
mesenchymal stem cells mediated angiogenesis by regulating
NF-κB/VEGF signaling. Am J Transl Res. 9:5538–5547. 2017.
|
|
52
|
Sun J, Song Y, Wang Z, Chen X, Gao P, Xu
Y, Zhou B and Xu H: Clinical significance of palliative gastrectomy
on the survival of patients with incurable advanced gastric cancer:
A systematic review and meta-analysis. BMC Cancer. 13:5772013.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Orditura M, Galizia G, Sforza V,
Gambardella V, Fabozzi A, Laterza MM, Andreozzi F, Ventriglia J,
Savastano B, Mabilia A, et al: Treatment of gastric cancer. World J
Gastroenterol. 20:1635–1649. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Kwee RM and Kwee TC: Role of imaging in
predicting response to neoadjuvant chemotherapy in gastric cancer.
World J Gastroenterol. 20:1650–1656. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Shitara K: Chemotherapy for advanced
gastric cancer: Future perspective in Japan. Gastric Cancer.
20:102–110. 2017. View Article : Google Scholar
|
|
56
|
Roberto M, Romiti A, Onesti CE, Zullo A,
Falcone R and Marchetti P: Evolving treatments for advanced gastric
cancer: Appraisal of the survival trend. Expert Rev Anticancer
Ther. 16:717–729. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
McMillin DW, Negri JM and Mitsiades CS:
The role of tumour-stromal interactions in modifying drug response:
Challenges and opportunities. Nat Rev Drug Discov. 12:217–228.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Zeng J, Chen S, Li C, Ye Z, Lin B, Liang
Y, Wang B, Ma Y, Chai X, Zhang X, et al: Mesenchymal stem/stromal
cells-derived IL-6 promotes nasopharyngeal carcinoma growth and
resistance to cisplatin via upregulating CD73 expression. J Cancer.
11:2068–2079. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Le Naour A, Prat M, Thibault B, Mével R,
Lemaitre L, Leray H, Joubert MV, Coulson K, Golzio M, Lefevre L, et
al: Tumor cells educate mesenchymal stromal cells to release
chemoprotective and immunomodulatory factors. J Mol Cell Biol.
12:202–215. 2020. View Article : Google Scholar :
|
|
60
|
Pasquier J, Gosset M, Geyl C,
Hoarau-Véchot J, Chevrot A, Pocard M, Mirshahi M, Lis R, Rafii A
and Touboul C: CCL2/CCL5 secreted by the stroma induce IL-6/PYK2
depen-dent chemoresistance in ovarian cancer. Mol Cancer.
17:472018. View Article : Google Scholar
|
|
61
|
Wang X: Stem cells in tissues, organoids,
and cancers. Cell Mol Life Sci. 76:4043–4070. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Polejaeva IA, Chen SH, Vaught TD, Page RL,
Mullins J, Ball S, Dai Y, Boone J, Walker S, Ayares DL, et al:
Cloned pigs produced by nuclear transfer from adult somatic cells.
Nature. 407:86–90. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Takahashi K, Tanabe K, Ohnuki M, Narita M,
Ichisaka T, Tomoda K and Yamanaka S: Induction of pluripotent stem
cells from adult human fibroblasts by defined factors. Cell.
131:861–872. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
He W, Liang B, Wang C, Li S, Zhao Y, Huang
Q, Liu Z, Yao Z, Wu Q, Liao W, et al: MSC-regulated lncRNA
MACC1-AS1 promotes stemness and chemoresistance through fatty acid
oxidation in gastric cancer. Oncogene. 38:4637–4654. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Ji R, Zhang B, Zhang X, Xue J, Yuan X, Yan
Y, Wang M, Zhu W, Qian H and Xu W: Exosomes derived from human
mesenchymal stem cells confer drug resistance in gastric cancer.
Cell Cycle. 14:2473–2483. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Chaudhary D, Trivedi RN, Kathuria A,
Goswami TK, Khandia R and Munjal A: In vitro and in vivo
immunomodulating properties of mesenchymal stem cells. Recent Pat
Inflamm Allergy Drug Discov. 12:59–68. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Su CY, Fu XL, Duan W, Yu PW and Zhao YL:
High density of CD68+ tumor-associated macrophages
predicts a poor prognosis in gastric cancer mediated by IL-6
expression. Oncol Lett. 15:6217–6224. 2018.PubMed/NCBI
|
|
68
|
Li W, Zhang X, Wu F, Zhou Y, Bao Z, Li H,
Zheng P and Zhao S: Gastric cancer-derived mesenchymal stromal
cells trigger M2 macrophage polarization that promotes metastasis
and EMT in gastric cancer. Cell Death Dis. 10:9182019. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Wang M, Chen B, Sun XX, Zhao XD, Zhao YY,
Sun L, Xu CG, Shen B, Su ZL, Xu WR and Zhu W: Gastric cancer
tissue-derived mesenchymal stem cells impact peripheral blood
mononuclear cells via disruption of Treg/Th17 balance to promote
gastric cancer progression. Exp Cell Res. 361:19–29. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Schmid P, Cortes J, Pusztai L, McArthur H,
Kümmel S, Bergh J, Denkert C, Park YH, Hui R, Harbeck N, et al:
Pembrolizumab for early triple-negative breast cancer. N Engl J
Med. 382:810–821. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Burtness B, Harrington KJ, Greil R,
Soulières D, Tahara M, de Castro G Jr, Psyrri A, Basté N, Neupane
P, Bratland Å, et al: Pembrolizumab alone or with chemotherapy
versus cetuximab with chemotherapy for recurrent or metastatic
squamous cell carcinoma of the head and neck (KEYNOTE-048): A
randomised, open-label, phase 3 study. Lancet. 394:1915–1928. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Kamath SD, Kalyan A and Benson A:
Pembrolizumab for the treatment of gastric cancer. Expert Rev
Anticancer Ther. 18:1177–1187. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Bang YJ, Kang YK, Catenacci DV, Muro K,
Fuchs CS, Geva R, Hara H, Golan T, Garrido M, Jalal SI, et al:
Pembrolizumab alone or in combination with chemotherapy as
first-line therapy for patients with advanced gastric or
gastroesophageal junction adenocarcinoma: Results from the phase II
nonrandomized KEYNOTE-059 study. Gastric Cancer. 22:828–837. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Fukuoka S, Hara H, Takahashi N, Kojima T,
Kawazoe A, Asayama M, Yoshii T, Kotani D, Tamura H, Mikamoto Y, et
al: Regorafenib plus nivolumab in patients with advanced gastric or
colorectal cancer: An open-label, dose-escalation, and
dose-expansion phase Ib trial (REGONIVO, EPOC1603). J Clin Oncol.
38:2053–2061. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Sun L, Wang Q, Chen B, Zhao Y, Shen B,
Wang H, Xu J, Zhu M, Zhao X, Xu C, et al: Gastric cancer
mesenchymal stem cells derived IL-8 induces PD-L1 expression in
gastric cancer cells via STAT3/mTOR-c-Myc signal axis. Cell Death
Dis. 9:9282018. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Song Y, Du H, Dai C, Zhang L, Li S, Hunter
DJ, Lu L and Bao C: Human adipose-derived mesenchymal stem cells
for osteoarthritis: A pilot study with long-term follow-up and
repeated injections. Regen Med. 13:295–307. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Ahn SY, Chang YS, Sung SI and Park WS:
Mesenchymal stem cells for severe intraventricular hemorrhage in
preterm infants: Phase I dose-escalation clinical trial. Stem Cells
Transl Med. 7:847–856. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Lin W, Huang L, Li Y, Fang B, Li G, Chen L
and Xu L: Mesenchymal stem cells and cancer: Clinical challenges
and opportunities. Biomed Res Int. 2019:28208532019. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Pakravan K, Babashah S, Sadeghizadeh M,
Mowla SJ, Mossahebi-Mohammadi M, Ataei F, Dana N and Javan M:
MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes
suppresses in vitro angiogenesis through modulating the
mTOR/HIF-1α/VEGF signaling axis in breast cancer cells. Cell Oncol
(Dordr). 40:457–470. 2017. View Article : Google Scholar
|
|
80
|
Zhang J, Hou L, Wu X, Zhao D, Wang Z, Hu
H, Fu Y and He J: Inhibitory effect of genetically engineered
mesenchymal stem cells with Apoptin on hepatoma cells in vitro and
in vivo. Mol Cell Biochem. 416:193–203. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Shojaati G, Khandaker I, Funderburgh ML,
Mann MM, Basu R, Stolz DB, Geary ML, Dos Santos A, Deng SX and
Funderburgh JL: Mesenchymal stem cells reduce corneal fibrosis and
inflammation via extracellular vesicle-mediated delivery of miRNA.
Stem Cells Transl Med. 8:1192–1201. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Wang M, Zhao C, Shi H, Zhang B, Zhang L,
Zhang X, Wang S, Wu X, Yang T, Huang F, et al: Deregulated
microRNAs in gastric cancer tissue-derived mesenchymal stem cells:
Novel biomarkers and a mechanism for gastric cancer. Br J Cancer.
110:1199–1210. 2014. View Article : Google Scholar : PubMed/NCBI
|
